Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sitia

Showing results (281-290 of 284) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 284 results.
The Journal of Experimental Medicine|December 6, 2017
High mobility group box 1 orchestrates tissue regeneration via CXCR4Mario Tirone, Ngoc Lan Tran, Chiara Ceriotti, et al.
Environmental Microbiology|April 29, 2020
The importance of naturally attenuated SARS-CoV-2in the fight against COVID-19Jean Armengaud, Agnès Delaunay-Moisan, Jean-Yves Thuret, et al.
Cell Death & Disease|February 15, 2023
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responsesLaura Raccosta, Maura Marinozzi, Susan Costantini, et al.
Nature Communications|January 8, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strengthMartina Spiga, Alessia Potenza, Zulma Magnani, et al.
Pageof 29

Showing results (281-290 of 284) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 284 results.
The Journal of Experimental Medicine|December 6, 2017
High mobility group box 1 orchestrates tissue regeneration via CXCR4Mario Tirone, Ngoc Lan Tran, Chiara Ceriotti, et al.
Environmental Microbiology|April 29, 2020
The importance of naturally attenuated SARS-CoV-2in the fight against COVID-19Jean Armengaud, Agnès Delaunay-Moisan, Jean-Yves Thuret, et al.
Cell Death & Disease|February 15, 2023
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responsesLaura Raccosta, Maura Marinozzi, Susan Costantini, et al.
Nature Communications|January 8, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strengthMartina Spiga, Alessia Potenza, Zulma Magnani, et al.
Pageof 29